ClonaCell-HY for Hybridomas, Kit (03800)

Complete kit for hybridoma generation

Advantage:
• Time savings: Hybridoma selection and cloning are combined into one step
• Resource savings: Single cell-derived hybridomas form visible discrete colonies in semi-solid medium, and are easy to pick and screen, and transfer to liquid medium for expansion
• Cloning efficiency: Individual cells are suspended and immobilized in semi-solid medium, preventing loss of rare, high-producing clones by overgrowth

Components:
• ClonaCell™-HY Medium A, 500 mL (Catalog #03801)
• ClonaCell™-HY Medium B, 500 mL (Catalog #03802)
• ClonaCell™-HY Medium C, 100 mL (Catalog #03803)
• ClonaCell™-HY Medium D, 90 mL (Catalog #03804)
• ClonaCell™-HY Medium E, 500 mL (Catalog #03805)
• ClonaCell™-HY PEG, 1.5 mL (Catalog #03806)

Application: Cell Culture, Hybridoma Generation
Cell Type: Hybridomas
species: Mouse, Rat, Other
Subtype: Semi-Solid Media, Specialized Media

Size: 1Kit

***購買請洽 台灣唯一 代理商: 卓昇有限公司 品質才有保障***

庫存單位 03800 分類

描述

ClonaCell™-HY Hybridoma Kit contains media and reagents for all steps in hybridoma development and monoclonal antibody production. The ClonaCell™-HY method uses a methylcellulose-based semi-solid selective medium to combine hybridoma selection and cloning into one step. Individual parental hybridoma clones and their progeny remain localized together in the semi-solid medium as they grow to form distinct colonies. This prevents the loss of rare clones by overgrowth from faster-growing cells, as can occur during selection in a liquid medium. The hybridoma colonies can be easily picked from the semi-solid medium by manual or robotic methods and dispersed into a liquid growth medium for screening and expansion. This kit has been verified for use in mouse and rat hydridoma development and monoclonal antibody production and reportedly is compatible for production, cloning, and expansion of hybridomas using lymphocytes from a variety of host animals including human, mouse, rat, and hamster.

額外資訊

Catalog No.

Product Name

Area of Interest

Antibody Development, Cell Line Development, Drug Discovery and Toxicity Testing, Hybridoma Generation

Unit